VOV.VN - Vietnam is starting phases 2 and 3 of its human clinical trial of the ARCT-154 vaccine against COVID-19 following the encouraging results of the first phase.

VOV.VN - Vietnam is going to recruit volunteers for clinical trials of ARCT-154 vaccine to see if it is effective against the mutated strain of the Delta variant which was first identified in India and has spread to more than 100 countries worldwide.

VOV.VN - Vingroup, a leading Vietnamese multi-sectoral conglomerate, plans to build a COVID-19 vaccine production plant in Hanoi with a designed capacity of between 100-200 million doses a year.